Citation Impact
Citing Papers
BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency
2013
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
2017 Standout
Triple negative breast cancer: unmet medical needs
2010
The Ensembl Variant Effect Predictor
2016 Standout
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Breast cancer
2019 Standout
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
2011
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
2012
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Breast cancer
2016 Standout
The effect of the hormonal milieu of pregnancy on deep infiltrating endometriosis: serial ultrasound assessment of changes in size and pattern of deep endometriotic lesions
2011
Targeted Therapy for Breast Cancer
2013
Dairy consumption during adolescence and endometriosis risk
2019 Standout
Ultrasound diagnosis of endometriosis and adenomyosis: State of the art
2018
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
2010
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis
2012 StandoutNobel
ESHRE guideline: management of women with endometriosis
2014 Standout
The role of nanobacteria in urologic disease
2006
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Preoperative and Postoperative Clinical and Transvaginal Ultrasound Findings of Adenomyosis in Patients With Deep Infiltrating Endometriosis
2014
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Cardiopulmonary Responses and Adherence to Exercise in Women Newly Diagnosed With Breast Cancer Undergoing Adjuvant Therapy
2006
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
2014
Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study
2012
Bone health in cancer patients: ESMO Clinical Practice Guidelines
2014
Role of bisphosphonates in postmenopausal women with breast cancer
2013
Clinical diagnosis of endometriosis: a call to action
2019
PARP Inhibitor Treatment in Ovarian and Breast Cancer
2011
Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal
2015
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Is Quality and Completeness of Reporting of Systematic Reviews and Meta-Analyses Published in High Impact Radiology Journals Associated with Citation Rates?
2015
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
2011
Therapeutic potential of PARP inhibitors for metastatic breast cancer
2011
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1
1999
Endometriosis: pathogenesis and treatment
2013 Standout
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
2012
Nanobacteria - propagating calcifying nanoparticles
2006
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Imaging modalities for the non-invasive diagnosis of endometriosis
2016
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
Role of Surgery in Endometriosis-Associated Subfertility
2013
Nanomaterials and nanoparticles: Sources and toxicity
2007 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Endometriosis
2020 Standout
Deep Infiltrating Endometriosis: Comparison Between 2‐Dimensional Ultrasonography (US), 3‐Dimensional US, and Magnetic Resonance Imaging
2017
Cancer Genome Landscapes
2013 StandoutScience
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Endometriosis
2018
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
2014 Standout
Factors affecting number of citations: a comprehensive review of the literature
2016 Standout
Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
2011
Works of CF Singer being referenced
Transvaginal sonography vs. clinical examination in the preoperative diagnosis of deep infiltrating endometriosis
2011
Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization
2004
Diagnostic accuracy of transvaginal ultrasound for non‐invasive diagnosis of bowel endometriosis: systematic review and meta‐analysis
2010
Combination of transvaginal sonography and clinical examination for preoperative diagnosis of pelvic endometriosis
2009
Safety and efficacy of the oral PARP inhibitor olaparib (AZD2281) in combination with paclitaxel for the first- or second-line treatment of patients with metastatic triple-negative breast cancer: Results from the safety cohort of a phase I/II multicenter trial.
2010
S1-2: Long-Term Follow-Up in ABCSG-12: Significantly Improved Overall Survival with Adjuvant Zoledronic Acid in Premenopausal Patients with Endocrine-Receptor–Positive Early Breast Cancer.
2011
NEWEST: a Phase II, randomised, neoadjuvant trial comparing fulvestrant 500 mg vs 250 mg in postmenopausal women with locally advanced, oestrogen receptor-positive (ER+) breast cancer
2008
Impact of body mass index (BMI) on endocrine therapy in premenopausal breast cancer patients: An analysis of the ABCSG-12 trial.
2010
Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids.
1997
Pathologic complete response (pCR) in patient subgroups: An analysis of ABCSG-24, a phase III, randomized study of anthracycline- and taxane-based neoadjuvant therapy with or without capecitabine in early breast cancer (EBC).
2010
Overall survival with adjuvant zoledronic acid in patients with premenopausal breast cancer with complete endocrine blockade: Long-term results from ABCSG-12.
2011
Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels
2004